Dattwyler Supported by Phil Baker
Dr. Dattwyler whose work is funded by a Small Business Innovative Research (SBIR) research grant, has a long-standing interest in the identification and use of specific and well-defined Borrelia peptides for the diagnosis of early Lyme disease. He has recently published a paper on the successful use of one such peptide for the diagnosis of early Lyme disease in an ELISA test; the results obtained compare well with those of the existing two-tiered procedure, as well as the C6-ELISA.
He is now examining the possibility of combining 5 or more such peptides in a single one-step assay for the better detection of early Lyme disease. No doubt, the specimens in the reference repository will enable him to compare the results obtained with his peptides to those obtained using other assays to determine superiority. This is truly exciting, cutting edge research. I am indeed proud to have assisted Dr. Dattwyler, as well as many other NIH grantees, in getting support for the outstanding work that they are doing. Clearly, positive efforts such as these will provide the knowledge we need to solve these and other problems related to Lyme disease.
Link to Letter
http://www.aldf.com/Poughkepse_Journal_Letter_to_the_Editor.pdf